Date
November 11-12, 2026 | 09:30 AM GMT
Location
Dubai, UAE
Dubai, UAE
This track explores the biological and neurological mechanisms underlying substance use and addictive behaviors. It focuses on how reward pathways, neurotransmitter systems, neuroplasticity, stress responses, and brain circuitry contribute to addiction initiation, maintenance, and relapse. Researchers and clinicians will discuss advances in neurobiological models, experimental approaches, and translational research connecting laboratory findings with clinical practice. The track also highlights emerging strategies for targeting neural mechanisms to develop more effective and individualized addiction interventions.
This track focuses on moving addiction treatment toward individualized, evidence-based care based on patients’ biological, psychological, behavioral, and social characteristics. Discussions will examine treatment-response prediction, pharmacogenomics, patient stratification, precision prescribing, and personalized behavioral interventions. The session will explore how clinical data, biomarkers, genetics, and digital technologies can support treatment selection and improve outcomes. Particular attention will be given to translating precision psychiatry concepts into practical addiction-care models.
This track examines the growing role of artificial intelligence and digital technologies in addiction research, diagnosis, prevention, and treatment. Topics include machine-learning prediction models, digital phenotyping, mobile health applications, wearable devices, telepsychiatry, and digital therapeutics. Researchers will explore how real-time behavioral and clinical data can identify risk patterns, predict relapse, and support personalized interventions. Ethical considerations, data privacy, algorithmic bias, and responsible implementation of AI in addiction care will also be discussed.
This track explores emerging pharmacological approaches for addiction and psychiatric disorders, including psychedelic-assisted therapies and novel therapeutic compounds. Discussions will cover mechanisms of action, clinical trials, treatment protocols, safety considerations, patient selection, and regulatory challenges. The track provides an opportunity to examine the therapeutic potential and limitations of emerging medicines while considering their integration with psychotherapy and conventional addiction treatment. Translational research and long-term treatment outcomes will also receive attention.
This track addresses the continuing global burden of opioid use disorder and advances in prevention, treatment, and recovery. Sessions will examine medication-based treatments, overdose prevention, opioid-related mortality, novel pharmacotherapies, withdrawal management, and long-term recovery strategies. Researchers will also discuss barriers to treatment access, stigma, healthcare disparities, and integrated models of care. The track aims to highlight innovative approaches that improve treatment retention, reduce relapse, prevent overdose, and strengthen outcomes for individuals affected by opioid dependence.
This track examines contemporary research surrounding alcohol, tobacco, vaping, and nicotine dependence. It will address biological and behavioral mechanisms, prevention strategies, dependence treatment, smoking cessation, and emerging patterns of nicotine consumption. Discussions will consider the impact of electronic cigarettes, novel nicotine products, alcohol-related psychiatric conditions, and population-level interventions. Researchers and clinicians will explore pharmacological, behavioral, digital, and public-health approaches designed to reduce dependence and improve long-term abstinence and health outcomes.
This track focuses on addictive and compulsive behaviors that increasingly affect mental health in the digital era. Topics include gambling disorder, gaming disorder, problematic internet use, excessive social-media engagement, and other emerging behavioral dependencies. Discussions will examine neurobiological and psychological mechanisms, diagnostic challenges, comorbid psychiatric conditions, and evidence-based interventions. Particular emphasis will be placed on understanding how technology, accessibility, reward mechanisms, and social environments influence problematic behaviors and the development of effective prevention and treatment strategies.
This track addresses the complex relationship between addiction and psychiatric comorbidities, emphasizing integrated approaches to diagnosis and treatment. Substance use disorders frequently coexist with depression, anxiety, PTSD, ADHD, psychotic disorders, personality disorders, and other mental health conditions. Sessions will explore shared biological mechanisms, diagnostic challenges, clinical management, suicide risk, and integrated treatment models. The track aims to promote collaborative psychiatric and addiction care that addresses both substance-related problems and underlying mental health needs.
This track highlights advances in biological approaches to understanding addiction vulnerability, diagnosis, prognosis, and treatment response. Researchers will explore genetic susceptibility, epigenetic mechanisms, molecular biomarkers, neuroimaging, EEG, PET, and functional MRI techniques. The sessions will examine how biological markers can identify individuals at increased risk, characterize disease mechanisms, and support precision treatment. Particular emphasis will be placed on translating laboratory discoveries into clinically useful tools for prediction, early intervention, and personalized addiction medicine.
This track explores the challenges of maintaining recovery and preventing relapse following addiction treatment. Discussions will address craving management, behavioral therapies, recovery-oriented care, rehabilitation, peer support, family involvement, and continuing-care models. Researchers will examine predictors of relapse and strategies for strengthening treatment adherence and long-term recovery. The track also considers social reintegration, employment, community support, and digital interventions that can help individuals maintain healthier lifestyles and achieve sustainable recovery beyond formal treatment settings.
This track focuses on substance use and addictive behaviors among children, adolescents, and young adults. It examines early risk factors, developmental neuroscience, family and social influences, school-based prevention, early intervention, and youth-focused treatment approaches. Sessions will address emerging concerns surrounding vaping, alcohol, cannabis, gaming, and digital behaviors. Researchers and public-health professionals will discuss strategies for reducing early exposure, identifying vulnerable populations, strengthening resilience, and developing effective prevention programs across schools, families, healthcare systems, and communities.
This track examines addiction from public-health, policy, social, and global perspectives. It explores harm-reduction strategies, overdose prevention, treatment accessibility, stigma reduction, healthcare inequalities, and evidence-based addiction policies. Discussions will compare approaches across countries and examine how socioeconomic conditions, healthcare infrastructure, and cultural factors influence addiction outcomes. The track aims to encourage collaboration between clinicians, researchers, policymakers, and community organizations to develop compassionate, equitable, and scientifically informed approaches to addiction prevention, treatment, and recovery.
Madrid, Spain - Oct 5, 2026
Abstracts enquiry
Finance enquiry
Contact Enquiry
Sponsors / Advertising
Meetings International Pte Ltd, 28 Maxwell Road, 03-05 Red Dot Traffic, Singapore, 069120.
